menu
    • menu

    Company profile for Onconic Therapeutics

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Onconic Therapeutics is at the forefront of pharmaceutical product development, dedicated to creating next-generation anti-cancer therapies. The company's focus lies in pioneering novel treatments that address cancer by concurrently inhibiting signal transduction agents associated with cancer cell growth and DNA damage repair enzymes in cancer cells. This innovative approach aims to provide healthcare professionals with effect...
    Onconic Therapeutics is at the forefront of pharmaceutical product development, dedicated to creating next-generation anti-cancer therapies. The company's focus lies in pioneering novel treatments that address cancer by concurrently inhibiting signal transduction agents associated with cancer cell growth and DNA damage repair enzymes in cancer cells. This innovative approach aims to provide healthcare professionals with effective anti-cancer drugs to enhance the treatment landscape for cancer patients.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Onconic Therapeuticskorearepublicofnew Flag
    Country
    Country
    South Korea
    Address
    Address
    11F, 12 Teheranro-26-gil, Gangnam, Seoul, 06236
    Telephone
    Telephone
    +82 234540780
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    http://onconic.co.kr/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/onconic-therapeutics/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Onconic Positive JAQBO Phase 3 Data At DDW 2024
    Onconic Positive JAQBO Phase 3 Data At DDW 2024

    30 May 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/onconic-therapeutics-announces-positive-phase-3-results-for-jaqbo-at-digestive-diseases-week-2024-302157760.html

    PR NEWSWIRE
    30 May 2024
    Share Share
    Onconic Announces Positive JAQBO Phase 3 Results At DDW 2024
    Onconic Announces Positive JAQBO Phase 3 Results At DDW 2024

    30 May 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/onconic-therapeutics-gibt-positive-phase-3-ergebnisse-fur-jaqbo-auf-der-digestive-diseases-week-2024-bekannt-302158371.html

    PR NEWSWIRE
    30 May 2024
    Share Share
    Onconic's JAQBO for GERD Approved in South Korea
    Onconic's JAQBO for GERD Approved in South Korea

    25 Apr 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/onconic-therapeutics-receives-mfds-approval-for-jaqbo-a-new-treatment-for-gastroesophageal-reflux-disease-gerd-302127461.html

    PR NEWSWIRE
    25 Apr 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search